epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Alprolix
    coagulation factor IX (recombinant), Fc fusion protein
  • remove Follistim AQ
    follitropin beta
  • remove Ultomiris (ravulizumab-cwvz)
    ravulizumab

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Alprolix (coagulation factor IX (recombinant), Fc fusion protein) + Follistim AQ (follitropin beta)

Monitor/Modify Tx


coagulation factor IX + follitropin

monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information